capital pools such as family offices and other patient investors, particularly across MENA and APAC. Its work includes designing capital strategies, guiding investor outreach, and aligning funding plans with long-term clinical and technological objectives. CarMa Global Enterprise emphasizes rigorous understanding of underlying science to shape clear, narrative-driven investor materials. It supports companies working on areas such as neurodegenerative disease, oncology, cell therapy platforms, and medical artificial intelligence architectures.